Cbfβ interacts with Runx2 and has a critical role in bone development (original) (raw)

• Mundlos, S. Cleidocranial dysplasia: clinical and molecular genetics. J. Med. Genet. 36, 177–182 (1999).
  CAS PubMed PubMed Central Google Scholar
• Zhou, G. et al. CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum. Mol. Genet. 8, 2311–2316 (1999).
  Article CAS Google Scholar
• Wang, Q. et al. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell 87, 697–708 (1996).
  Article CAS Google Scholar
• Sasaki, K. et al. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core-binding factor β. Proc. Natl Acad. Sci. USA 93, 12359–12363 (1996).
  Article CAS Google Scholar
• Kundu, M. et al. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb_–_MYH11. Blood 100, 2449–2456 (2002).
  Article CAS Google Scholar
• Komori, T. et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755–764 (1997).
  Article CAS Google Scholar
• Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765–771 (1997).
  Article CAS Google Scholar
• Kagoshima, H., Akamatsu, Y., Ito, Y. & Shigesada, K. Functional dissection of the α and β subunits of transcription factor PEBP2 and the redox susceptibility of its DNA binding activity. J. Biol. Chem. 271, 33074–33082 (1996).
  Article CAS Google Scholar
• Miller, J.D., Stacy, T., Liu, P.P. & Speck, N.A. Core-binding factor β (CBFβ), but not CBFβ-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFβ-deficient embryonic stem cells. Blood 97, 2248–2256 (2001).
  Article CAS Google Scholar
• Kim, I.S., Otto, F., Zabel, B. & Mundlos, S. Regulation of chondrocyte differentiation by Cbfa1. Mech. Dev. 80, 159–170 (1999).
  Article CAS Google Scholar
• Zhang, Y.W. et al. A RUNX2/PEBP2α A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc. Natl Acad. Sci. USA 97, 10549–10554 (2000).
  Article CAS Google Scholar
• Harada, H. et al. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J. Biol. Chem. 274, 6972–6978 (1999).
  Article CAS Google Scholar
• Otto, F., Kanegane, H. & Mundlos, S. Mutations in the RUNX2 gene in patients with cleidocranial dysplasia. Hum. Mutat. 19, 209–216 (2002).
  Article CAS Google Scholar
• Tahirov, T.H. et al. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFβ. Cell 104, 755–767 (2001).
  Article CAS Google Scholar
• Warren, A.J., Bravo, J., Williams, R.L. & Rabbitts, T.H. Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFβ. EMBO J. 19, 3004–3015 (2000).
  Article CAS Google Scholar
• Thirunavukkarasu, K., Mahajan, M., McLarren, K.W., Stifani, S. & Karsenty, G. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfβ. Mol. Cell. Biol. 18, 4197–4208 (1998).
  Article CAS Google Scholar
• Prince, M. et al. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J. Cell. Biochem. 80, 424–440 (2001).
  Article CAS Google Scholar
• Javed, A. et al. Runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins. Mol. Cell. Biol. 21, 2891–2905 (2001).
  Article CAS Google Scholar
• Hanai, J. et al. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J. Biol. Chem. 274, 31577–31582 (1999).
  Article CAS Google Scholar
• Shirakabe, K., Terasawa, K., Miyama, K., Shibuya, H. & Nishida, E. Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5. Genes Cells 6, 851–856 (2001).
  Article CAS Google Scholar
• Javed, A. et al. Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBFα/AML/PEBP2α) dependent activation of tissue-specific gene transcription. J. Cell. Sci. 113, 2221–2231 (2000).
  CAS PubMed Google Scholar
• D'Alonzo, R.C., Selvamurugan, N., Karsenty, G. & Partridge, N.C. Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. J. Biol. Chem. 277, 816–822 (2002).
  Article CAS Google Scholar
• Gutierrez, S. et al. CCAAT/enhancer-binding proteins (C/EBP) β and Δ activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J. Biol. Chem. 277, 1316–1323 (2002).
  Article CAS Google Scholar
• Speck, N.A. & Gilliland, D.G. Core-binding factors in haematopoiesis and leukaemia. Nature Rev. Cancer 2, 502–513 (2002).
  Article CAS Google Scholar
• Yoshida, T. et al. Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype–phenotype correlations. Am. J. Hum. Genet. 71, 724–738 (2002).
  Article Google Scholar
• Miller, J. et al. The core-binding factor β subunit is required for bone formation and hematopoietic maturation. Nature Genet. 32, 645–649 (2002).
  Article CAS Google Scholar
• Yoshida, C.A. et al. Core-binding factor β interacts with Runx2 and is required for skeletal development. Nature Genet. 32, 633–638 (2002).
  Article CAS Google Scholar
• St-Jacques, B., Hammerschmidt, M. & McMahon, A.P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 13, 2072–2086 (1999).
  Article CAS Google Scholar
• Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L. & Karsenty, G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747–754 (1997).
  Article CAS Google Scholar
• Meyers, S., Lenny, N., Sun, W. & Hiebert, S.W. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene 13, 303–312 (1996).
  CAS PubMed Google Scholar
• Adya, N., Stacy, T., Speck, N.A. & Liu, P.P. The leukemic protein core-binding factor β (CBFβ)-smooth-muscle myosin heavy chain sequesters CBFα2 into cytoskeletal filaments and aggregates. Mol. Cell. Biol. 18, 7432–7443 (1998).
  Article CAS Google Scholar
• Banerjee, C. et al. Differential regulation of the two principal Runx2/Cbfa1 N-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 142, 4026–4039 (2001).
  Article CAS Google Scholar